Business
Pfizer is negotiating a price of $370 to $380 for each share, a person familiar with the discussions said.
Hi, what are you looking for?
Pfizer is negotiating a price of $370 to $380 for each share, a person familiar with the discussions said.
Bloomberg reports that Teva is working with Barclays Bank on a takeover bid for Mylan.
The Israel Patent Office has granted Israel’s Oramed Pharmaceuticals, a developer of oral drug delivery systems, a patent for its invention, titled “Methods and...
– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has announced : the Food and Drug Administration (FDA) approval and the launch of the...
Billionaire investor George Soros may have an interest in Juno Therapeutics, an immunotherapy stock that had its IPO last Friday, multimedia financial services company...
Originally published by The Jewish Press. The Israeli-bases One World Cannabis (OWC) company is going to be traded over the counter on Wall Street...
– The biotech sector has been outperforming the S&P 500, and some money managers continue to buy even as others are concerned about...
– Valeant Pharmaceuticals International Inc is abandoning its growth-by-acquisitions strategy for the time being to try to reduce debt, boost its stock price and...
Israel’s Immune Pharmaceuticals Inc., a clinical stage biopharmaceutical company that engages in the development and commercialization of targeted therapeutics for the treatment of inflammatory...
– Activist investor William “Bill” Ackman said on Tuesday he supports the $66 billion deal in which Actavis PLC will buy Allergan Inc and...